Rethinking Medicinal Cannabis. We are Chilam. A Life Science Company. Chilam is a life science company aiming to be a leading force in patient-led, innovative medicinal cannabis. We exist to rethink medicinal cannabis by creating technology-driven, cannabinoid-based medicine to address significant areas of unmet clinical need. Ultimately, improving the lives of millions of patients around the world. Our targeted innovation has commenced with female pain. Founded in 2019, Chilam is UK registered and headquartered. Our operations are in Europe where we are fully licensed for the research and development, processing, manufacture, and export of active pharmaceutical ingredients (API) including Tetrahydrocannabinoil (THC). Our research and development and processing facility has been designed and built to European Pharmacopeia standards since day one and will be an emissions net-positive site, powered by renewable energy. Our innovation roadmap is centered around the intersection of botanical prescription medicine and digital disruption for end patients.